Towards clinical application of pronuclear transfer to prevent mitochondrial DNA disease by Hyslop, LA, Blakeley, P, Craven, L, Richardson, J, Fogarty, NME, Fragouli, E, Lamb, M, Wamaitha, SE, Prathalingam, N, Zhang, Q, O'Keefe, H, Takeda, Y, Arizzi, L, Alfarawati, S, Tuppen, HA, Irving, L, Kalleas, D, Choudhary, M, Wells, D, Murdoch, AP, Turnbull, DM, Niakan, KK, Herbert, M

Pathogenic variants in MT-ATP6: A United Kingdom–based mitochondrial disease cohort study by Ng, YS, Martikainen, MH, Gorman, GS, Blain, A, Bugiardini, E, Bunting, A, Schaefer, AM, Alston, CL, Blakely, EL, Sharma, S, Hughes, I, Lim, A, Degoede, C, McEntagart, M, Spinty, S, Horrocks, I, Roberts, M, Woodward, CE, Chinnery, PF, Horvath, R, Nesbitt, V, Fratter, C, Poulton, J, Hanna, MG, Pitceathly, RDS, Taylor, RW, Turnbull, DM, McFarland, R